bms3 Search Results


limk inhibitor bms 3  (MedChemExpress)
94
MedChemExpress limk inhibitor bms 3
Limk Inhibitor Bms 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/limk inhibitor bms 3/product/MedChemExpress
Average 94 stars, based on 1 article reviews
limk inhibitor bms 3 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
molecule named bms3  (TargetMol)
90
TargetMol molecule named bms3
Molecule Named Bms3, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule named bms3/product/TargetMol
Average 90 stars, based on 1 article reviews
molecule named bms3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
thin wall micro-bms-3 nmr tube  (Shigemi Inc)
90
Shigemi Inc thin wall micro-bms-3 nmr tube
Thin Wall Micro Bms 3 Nmr Tube, supplied by Shigemi Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thin wall micro-bms-3 nmr tube/product/Shigemi Inc
Average 90 stars, based on 1 article reviews
thin wall micro-bms-3 nmr tube - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bare metal stent (bms) 3–13  (OrbusNeich)
90
OrbusNeich bare metal stent (bms) 3–13
Clinical and procedural characteristics.
Bare Metal Stent (Bms) 3–13, supplied by OrbusNeich, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bare metal stent (bms) 3–13/product/OrbusNeich
Average 90 stars, based on 1 article reviews
bare metal stent (bms) 3–13 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
liberte bms 3.0×16  (Boston Scientific Corporation)
90
Boston Scientific Corporation liberte bms 3.0×16
Clinical and procedural characteristics.
Liberte Bms 3.0×16, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liberte bms 3.0×16/product/Boston Scientific Corporation
Average 90 stars, based on 1 article reviews
liberte bms 3.0×16 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
control bms 3.0×12  (Abbott Laboratories)
90
Abbott Laboratories control bms 3.0×12
Representative histology of Arterial Remodeling Technologies bioresorbable scaffold <t>(</t> <t>ART</t> ‐ BRS ) (A) and bare metal stent ( <t>BMS</t> ) (C) with coregistered images of optical coherence tomography ( ART ‐ BRS , B; BMS , D) in a porcine coronary artery model from 1 to 36 months.
Control Bms 3.0×12, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control bms 3.0×12/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
control bms 3.0×12 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bms 3.0 x pro-kinetic energy  (Biotronik GmbH)
90
Biotronik GmbH bms 3.0 x pro-kinetic energy
Representative histology of Arterial Remodeling Technologies bioresorbable scaffold <t>(</t> <t>ART</t> ‐ BRS ) (A) and bare metal stent ( <t>BMS</t> ) (C) with coregistered images of optical coherence tomography ( ART ‐ BRS , B; BMS , D) in a porcine coronary artery model from 1 to 36 months.
Bms 3.0 X Pro Kinetic Energy, supplied by Biotronik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms 3.0 x pro-kinetic energy/product/Biotronik GmbH
Average 90 stars, based on 1 article reviews
bms 3.0 x pro-kinetic energy - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
gazelle bms 3  (Biosensors International)
90
Biosensors International gazelle bms 3
Representative histology of Arterial Remodeling Technologies bioresorbable scaffold <t>(</t> <t>ART</t> ‐ BRS ) (A) and bare metal stent ( <t>BMS</t> ) (C) with coregistered images of optical coherence tomography ( ART ‐ BRS , B; BMS , D) in a porcine coronary artery model from 1 to 36 months.
Gazelle Bms 3, supplied by Biosensors International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gazelle bms 3/product/Biosensors International
Average 90 stars, based on 1 article reviews
gazelle bms 3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bms-3  (BOC Sciences)
N/A
BMS-3, a LIMK1 inhibitor, could be probably influence the migration and cycle progression of cells so that has patential value in studying its effect against cancer.
   Buy from Supplier
bms-3  (Aladdin Scientific Corporation)
N/A
BMS-3 is a potent LIMK inhibitor with IC50s of 5 nM and 6 nM for LIMK1 and LIMK2, respectively.
   Buy from Supplier
bms-3  (Biosynth Carbosynth)
N/A
   Buy from Supplier
bms 3  (Cayman Chemical)
N/A
BMS 3 is a potent inhibitor of activated LIM domain kinases LIMK1 and LIMK2 ICs 5 and 6 nM respectively It is used to study the role of activated LIMK isoforms in the signaling of
   Buy from Supplier

Image Search Results


Clinical and procedural characteristics.

Journal: Acute Cardiac Care

Article Title: Distal ‘buddy-in-jail’ technique: a complementary ‘Jail with stent’ method for stent delivery

doi: 10.3109/17482941.2013.869342

Figure Lengend Snippet: Clinical and procedural characteristics.

Article Snippet: Despite this debulking and the presence of the BMW buddy wire, a bare metal stent (BMS) 3–13 (Azule TM SDS, OrbusNeich TM ) failed to reach the target distal lesion: the stent was unable to cross the bend at the level of the residual mid RCA lesion.

Techniques:

Representative histology of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) (A) and bare metal stent ( BMS ) (C) with coregistered images of optical coherence tomography ( ART ‐ BRS , B; BMS , D) in a porcine coronary artery model from 1 to 36 months.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up

doi: 10.1161/JAHA.117.005693

Figure Lengend Snippet: Representative histology of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) (A) and bare metal stent ( BMS ) (C) with coregistered images of optical coherence tomography ( ART ‐ BRS , B; BMS , D) in a porcine coronary artery model from 1 to 36 months.

Article Snippet: ART‐BRS (Arterial Remodeling Technologies, Paris, France) 3.0×11 mm and control BMS (Multilink Vision, Abbott, Santa Clara, CA) 3.0×12 mm were randomly implanted into the major coronary arteries and had a stent/scaffold‐to‐artery ratio of ≈1.1 to 1.2:1.0 in the coronary arteries of healthy Yucatan female or castrated male miniswine (30‐50 weeks, Lone Star Laboratory Swine, Sioux Center, IA) via femoral access following standard procedures as previously described.

Techniques: Tomography

Measurement of optical coherence tomography ( OCT ) (A) and strut classification (%) (B) of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) and bare metal stent ( BMS ). Line graphs show stent/scaffold area (a), lumen area (b), and area stenosis relative to the reference vessel segment (c) by optical coherence tomography analysis. The blue line represents BRS , and the red line represents BMS . Data are presented as mean±standard deviation. C, Representative images of strut classification by optical coherence tomography.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up

doi: 10.1161/JAHA.117.005693

Figure Lengend Snippet: Measurement of optical coherence tomography ( OCT ) (A) and strut classification (%) (B) of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) and bare metal stent ( BMS ). Line graphs show stent/scaffold area (a), lumen area (b), and area stenosis relative to the reference vessel segment (c) by optical coherence tomography analysis. The blue line represents BRS , and the red line represents BMS . Data are presented as mean±standard deviation. C, Representative images of strut classification by optical coherence tomography.

Article Snippet: ART‐BRS (Arterial Remodeling Technologies, Paris, France) 3.0×11 mm and control BMS (Multilink Vision, Abbott, Santa Clara, CA) 3.0×12 mm were randomly implanted into the major coronary arteries and had a stent/scaffold‐to‐artery ratio of ≈1.1 to 1.2:1.0 in the coronary arteries of healthy Yucatan female or castrated male miniswine (30‐50 weeks, Lone Star Laboratory Swine, Sioux Center, IA) via femoral access following standard procedures as previously described.

Techniques: Tomography, Standard Deviation

Representative scanning electron microscopy images of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) at 1 and 3 months following implantation in porcine coronary arteries. The low‐power images show complete strut coverage at 1 month in both ART ‐ BRS (A) and bare metal stent ( BMS ) (B), with similar findings at 3 months (C, ART ‐ BRS ; D, BMS ). High‐power images also show complete endothelialization by neointima with cells arranged in spindle and cobblestone morphology and showing well‐formed cell‐to‐cell contacts in both ART ‐ BRS and BMS .

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up

doi: 10.1161/JAHA.117.005693

Figure Lengend Snippet: Representative scanning electron microscopy images of Arterial Remodeling Technologies bioresorbable scaffold ( ART ‐ BRS ) at 1 and 3 months following implantation in porcine coronary arteries. The low‐power images show complete strut coverage at 1 month in both ART ‐ BRS (A) and bare metal stent ( BMS ) (B), with similar findings at 3 months (C, ART ‐ BRS ; D, BMS ). High‐power images also show complete endothelialization by neointima with cells arranged in spindle and cobblestone morphology and showing well‐formed cell‐to‐cell contacts in both ART ‐ BRS and BMS .

Article Snippet: ART‐BRS (Arterial Remodeling Technologies, Paris, France) 3.0×11 mm and control BMS (Multilink Vision, Abbott, Santa Clara, CA) 3.0×12 mm were randomly implanted into the major coronary arteries and had a stent/scaffold‐to‐artery ratio of ≈1.1 to 1.2:1.0 in the coronary arteries of healthy Yucatan female or castrated male miniswine (30‐50 weeks, Lone Star Laboratory Swine, Sioux Center, IA) via femoral access following standard procedures as previously described.

Techniques: Electron Microscopy

Summary of Studied Animals and Implanted Materials for Light Microscopy, Scanning Electron Microscopy, and Gel Permeation Chromatography

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up

doi: 10.1161/JAHA.117.005693

Figure Lengend Snippet: Summary of Studied Animals and Implanted Materials for Light Microscopy, Scanning Electron Microscopy, and Gel Permeation Chromatography

Article Snippet: ART‐BRS (Arterial Remodeling Technologies, Paris, France) 3.0×11 mm and control BMS (Multilink Vision, Abbott, Santa Clara, CA) 3.0×12 mm were randomly implanted into the major coronary arteries and had a stent/scaffold‐to‐artery ratio of ≈1.1 to 1.2:1.0 in the coronary arteries of healthy Yucatan female or castrated male miniswine (30‐50 weeks, Lone Star Laboratory Swine, Sioux Center, IA) via femoral access following standard procedures as previously described.

Techniques: Light Microscopy, Electron Microscopy